Diabetes was already an epidemic before the novel coronavirus struck. But some researchers now suspect that COVID-19 can trigger the condition. Approximately 14% of patients with severe COVID-19 develop the disease, according to a meta-analysis recently published in the journal Diabetes, Obesity and Metabolism.
To arrive at that thesis, the researchers analyzed eight studies. Half of those came from China, while two came from Italy and two from the U.S. The diabetes rate (13.4%) was lower in the China group than the rate in the combined U.S.–Italy group (15.4%).
Get the full story from our sister site, Drug Delivery Business.
